This HTML5 document contains 69 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q66343529
rdf:type
wikibase:Item
schema:description
klinisch onderzoek клінічне випробування ensayu clínicu clinical trial
rdfs:label
Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy
skos:prefLabel
Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy
schema:name
Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy
p:P1476
wds:Q66343529-F82AB946-E0F7-4141-BFA2-465FED7319C5
wdt:P1476
A Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Triple Fixed Dose Combination Therapy With Olmesartan Medoxomil 20mg, Amlodipine 5mg and Hydrochlorothiazide 12.5mg in Patients With Hypertension Not Controlled With Dual Fixed Dose Combination Therapy With Olmesartan Medoxomil 20mg and Hydrochlorothiazide 12.5mg
p:P582
wds:Q66343529-513B20B9-5862-439B-BF80-0B4310A239C1
wdt:P582
2014-08-01T00:00:00Z
p:P31
wds:Q66343529-F43A71B4-1F3D-4DBB-B838-5C1AF63338E1
wdt:P31
wd:Q30612
p:P580
wds:Q66343529-690AA51C-AE98-4E54-A90D-786C80AD0062
wdt:P580
2013-04-01T00:00:00Z
p:P6153
wds:Q66343529-379FEB94-F894-46AB-BDEB-9691385622BD wds:Q66343529-5BE61E2C-8BE2-454C-A18E-C543D3C26C11 wds:Q66343529-5CB7FD5F-2D48-4B1B-A1AE-3CBD8A01F699 wds:Q66343529-64CC9EC4-F8B6-4C5C-86B9-631C9645D7B6 wds:Q66343529-6CFBE4E9-5A29-4702-BAF5-A50A0B56E69E wds:Q66343529-6F81E6CB-8712-4BA5-92C9-EB6581360898 wds:Q66343529-777F23B7-99B6-4836-8AE7-6AFDBCFD7FE6 wds:Q66343529-9052A193-540C-4EC7-ABAA-25B16808F9FF wds:Q66343529-9912B1C4-D7DF-41F9-A9AD-DC251A4E326E wds:Q66343529-0DBA37D6-C553-4EC9-8C51-6031566BE1E4 wds:Q66343529-161B816F-2FEE-44A1-B672-FF627ED25D04 wds:Q66343529-9D3E4CB1-35E4-42D3-9FB7-17522E379A56 wds:Q66343529-AE0257B3-6CF3-4A0C-B79E-4D54C8100D2F wds:Q66343529-B6032845-2C46-4F42-BFE2-B47FBB8602C9 wds:Q66343529-D3E9C28F-34DD-41A8-9841-4B5ECEB9778F wds:Q66343529-D6BA38FD-0FD2-42FA-BBD0-C687F6E4EEAE wds:Q66343529-E1EEB0B1-D674-46E2-A26E-D6C972C28CB7
wdt:P6153
wd:Q16095606 wd:Q30253976 wd:Q4803501 wd:Q41790 wd:Q496536 wd:Q139779 wd:Q482724 wd:Q30280529 wd:Q489488 wd:Q626783 wd:Q7451677 wd:Q4403855 wd:Q623851 wd:Q39988 wd:Q27952693 wd:Q12591204 wd:Q39997
p:P2899
wds:Q66343529-81B7AD19-95FE-49B8-95D3-F140855E50E8
wdt:P2899
20
p:P1050
wds:Q66343529-8A18D4A7-CF18-4A87-83EB-6C5841E9A8B9 wds:Q66343529-A7E572EC-1989-43C0-86BB-4769C0D40FAC
wdt:P1050
wd:Q41861 wd:Q988405
p:P1132
wds:Q66343529-261A2193-17DB-4A5D-AB32-6540B1E7F852
wdt:P1132
344
p:P4135
wds:Q66343529-870FCA5B-BDEF-40F7-990E-FE50052846D8
wdt:P4135
75
p:P8363
wds:Q66343529-E9AF8DE0-7A5A-4DB0-A4AE-EF3D7E691A95
wdt:P8363
wd:Q78089383
p:P3098
wds:Q66343529-3266E92D-9582-484F-B679-2EA629F0775A
wdt:P3098
NCT01838850
p:P6099
wds:Q66343529-E89CC7C3-B47B-49F0-AB96-61C99BC7BB87
wdt:P6099
wd:Q42824827